Davis R M Inc Eli Lilly & CO Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Davis R M Inc holds 36,236 shares of LLY stock, worth $27.8 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

36,236

Previous 32,550 11.32%

Holding current value

$27.8 Million

Previous $29.5 Million 8.93%

% of portfolio

0.63%

Previous 0.61%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $2.85 Million - $3.54 Million	3,686 Added 11.32%	36,236 $32.1 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $2.52 Million - $3.16 Million	3,473 Added 11.94%	32,550 $29.5 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $3.14 Million - $4.2 Million	5,296 Added 22.27%	29,077 $22.6 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $6.06 Million - $7.14 Million	11,539 Added 94.26%	23,781 $13.9 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.73 Million - $3.76 Million	6,273 Added 105.09%	12,242 $6.58 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $4,208 - $5,627	-12 Reduced 0.2%	5,969 $2.8 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $34,169 - $40,130	-110 Reduced 1.81%	5,981 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $24,759 - $28,849	77 Added 1.28%	6,091 $2.23 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 0.82%	6,014 $1.95 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $202,357 - $237,598	-726 Reduced 10.69%	6,064 $1.97 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $99,743 - $123,955	425 Added 6.68%	6,790 $1.94 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $42,721 - $53,017	190 Added 3.08%	6,365 $1.76 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $39,444 - $48,542	-178 Reduced 2.8%	6,175 $1.43 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $14,444 - $18,683	-80 Reduced 1.24%	6,353 $1.46 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $31,549 - $40,842	-192 Reduced 2.9%	6,433 $1.2 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $90,930 - $120,323	697 Added 11.76%	6,625 $1.12 Million
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $8,543 - $9,292	-80 Reduced 1.33%	5,928 $663,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $59,383 - $69,315	-536 Reduced 8.19%	6,008 $666,000
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $334,375 - $393,584	-3,004 Reduced 31.46%	6,544 $849,000
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $192,949 - $216,162	-1,822 Reduced 16.02%	9,548 $1.11 Million
Q3 2018 Oct 17, 2018	BUY	$85.86 - $107.31 $8,671 - $10,838	101 Added 0.9%	11,370 $1.22 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $32,929 - $37,792	-435 Reduced 3.72%	11,269 $962,000
Q1 2018 Apr 19, 2018	SELL	$74.21 - $87.6 $57,883 - $68,328	-780 Reduced 6.25%	11,704 $906,000
Q4 2017 Jan 16, 2018	BUY	$81.94 - $87.89 $8,194 - $8,789	100 Added 0.81%	12,484 $1.05 Million
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $954,434 - $1.06 Million	12,384	12,384 $1.06 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account